Policy | December 20, 2023
Norms for fixing prices of medicines
NPPA fixes the ceiling price of scheduled formulations as per the extant provisions of DPCO, 201
NPPA fixes the ceiling price of scheduled formulations as per the extant provisions of DPCO, 201
Announces changes in the commercial organization to incorporate Seagen and improve focus, speed and execution
Accelerating FDA submission and confirming potential to become first approved biologic for this serious disease
Impressive safety and efficacy for solid cancer patients followed by global clinical study plan
Diofan Ultra736 provides ultra-high water vapor barrier with excellent thermoformability, unlocking the potential to design thinner and more sustainable blister films
Bains has stepped down from his role on the Biocon Board as an Independent Director with immediate effect
SÜDPACK customers also benefit when it comes to processing PharmaGuard
This indigenously developed enhanced care technology is designed to continuously monitor and detect early signs of deterioration in a patient's condition
The deal represents a total transaction value of up to $36 million with an initial upfront consideration of $14 million
Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
Subscribe To Our Newsletter & Stay Updated
